Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism

CONTEXT: Conventional hypoparathyroidism treatment with oral calcium and active vitamin D is aimed at correcting hypocalcemia but does not address other physiologic defects caused by PTH deficiency. OBJECTIVE: To evaluate long-term safety and tolerability of recombinant human PTH (1-84) [rhPTH(1-84)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannstadt, Michael, Clarke, Bart L, Bilezikian, John P, Bone, Henry, Denham, Douglas, Levine, Michael A, Peacock, Munro, Rothman, Jeffrey, Shoback, Dolores M, Warren, Mark L, Watts, Nelson B, Lee, Hak-Myung, Sherry, Nicole, Vokes, Tamara J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760337/
https://www.ncbi.nlm.nih.gov/pubmed/31369089
http://dx.doi.org/10.1210/jc.2019-01010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760337/
https://www.ncbi.nlm.nih.gov/pubmed/31369089
http://dx.doi.org/10.1210/jc.2019-01010

Ejemplares similares